Ultragenyx Pharmaceutical... (RARE)
NASDAQ: RARE
· Real-Time Price · USD
29.68
0.67 (2.31%)
At close: Aug 15, 2025, 3:59 PM
29.87
0.62%
After-hours: Aug 15, 2025, 07:57 PM EDT
Ultragenyx Pharmaceutical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -114.95M | -151.08M | -133.38M | -133.52M | -131.6M | -170.68M | -123.19M | -159.65M | -159.83M | -163.97M | -151.83M | -245.11M | -158.16M | -152.32M | -122.46M | -73M | -122.43M | -136.14M |
Depreciation & Amortization | -11.77M | 8.99M | 9.08M | -27.52M | 8.86M | 8.85M | 8.22M | 7.19M | 5.36M | 5.24M | 4.96M | 4.69M | 4.48M | 4.09M | 3.53M | 3.22M | 3.12M | 3.37M |
Stock-Based Compensation | 38.53M | 39.92M | 40.16M | 41.57M | 39.36M | 36.93M | 33.74M | 34.88M | 34.65M | 31.95M | 29.36M | 35.76M | 35.86M | 29.4M | 26.82M | 26.79M | 27.09M | 24.25M |
Other Working Capital | 17.48M | -17.48M | 45.85M | 12.72M | -7M | 6.55M | -1.62M | 4.99M | 12.11M | -2M | 122K | 5.87M | -1.19M | 5.92M | -31.17M | -11.72M | -21.18M | -52.13M |
Other Non-Cash Items | -76.71M | -7.67M | -18.11M | 21.65M | 23.78M | 107.39M | 123.19M | -1.83M | -27K | 8.28M | 6.97M | 87.14M | 12.65M | 13M | -1.14M | 3.96M | 4.01M | 4.87M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -139.17M | -1.26M | -3.48M | n/a | -1.64M | n/a | n/a | n/a | 18.21M | -23.71M | 32.62M | 21.56M |
Change in Working Capital | 56.63M | -56.63M | 22.75M | 30.83M | 16.36M | -56.02M | 13.3M | 2.8M | 7.16M | -38.36M | 21.85M | 22.17M | 27.91M | -11.69M | 20.69M | 3.1M | -9.77M | -77.26M |
Operating Cash Flow | -108.27M | -166.47M | -79.5M | -67M | -76.96M | -190.73M | -83.9M | -117.87M | -116.16M | -156.87M | -90.34M | -95.34M | -77.26M | -117.52M | -54.34M | -59.65M | -65.36M | -159.35M |
Capital Expenditures | 12.54M | -16.32M | -654K | -1.62M | -4.51M | -13.21M | -1.6M | -3.69M | -16.44M | -25.03M | -26.97M | -26.05M | -30.92M | -62.18M | -16.05M | -20.56M | -20.07M | -16.41M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M | n/a | -2.5M | n/a | 366K | -75.39M | n/a | n/a | 79.84M | n/a | n/a | n/a |
Purchase of Investments | -15.5M | n/a | -15.93M | -367.38M | -3.37M | -21.93M | -221.59M | -139.48M | -103.28M | -62.02M | -198.57M | -210.88M | 890K | -206.17M | -94.78M | -253.06M | -259.12M | -405.23M |
Sales Maturities Of Investments | 89.45M | 136.99M | 119.45M | 93.7M | 68.49M | 131.64M | 116.45M | 207.9M | 219.53M | 202.31M | 54.18M | 150.64M | 111.84M | 228.41M | 180.34M | 233.35M | 237.94M | 239.22M |
Other Investing Acitivies | -308K | -15.78M | -127K | -203K | -41K | -2.06M | -271K | -428K | 2.1M | -3.95M | -604K | -177K | -2.64M | 2.58M | -80.3M | -487K | -21.18M | -166.01M |
Investing Cash Flow | 71.17M | 119.89M | 102.73M | -275.5M | 60.56M | 94.44M | -107.02M | 64.3M | 99.42M | 111.3M | -171.6M | -161.86M | 79.17M | -37.36M | 69.06M | -40.76M | -41.25M | -182.42M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | 58K | -58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.92M | 157K | 3.19M | 7M | 384.94M | -58K | 4.15M | 442K | 33.02M | -722K | 1.88M | 491.88M | 5.84M | -143K | 6.78M | 7.55M | 12.63M | 12.65M |
Financial Cash Flow | 83.65M | 157K | 3.19M | 11.17M | 384.94M | -58K | 330.61M | 25.23M | 33.02M | -722K | 1.88M | 491.88M | 5.84M | 1.61M | 85.72M | 7.55M | 12.63M | 12.65M |
Net Cash Flow | 49.47M | -44.98M | 23.95M | -326.65M | 368.31M | -97.04M | 144.85M | -29.06M | 16.14M | -46.07M | -258.71M | 233.59M | 6.51M | -153.38M | 100.05M | -93.34M | -93.53M | -329.89M |
Free Cash Flow | -95.73M | -182.8M | -80.16M | -68.61M | -81.47M | -203.94M | -85.5M | -121.57M | -132.6M | -181.9M | -117.31M | -121.39M | -108.18M | -179.71M | -70.39M | -80.21M | -85.43M | -175.76M |